Spotlight On gMG
Welcome to Spotlight On gMG, your go-to source for the latest updates advancing our understanding and management of generalized myasthenia gravis (gMG). Join leading experts as they offer an in-depth examination of the pathophysiology, diagnosis, and treatment of this rare and complex autoimmune neuromuscular disorder.
1-11 of 11
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
NeuroFrontiersUpdates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
Richard Nowak, MD, MS
Generalized Myasthenia Gravis Management: Evaluating Long-Term Effects
NeuroFrontiersGeneralized Myasthenia Gravis Management: Evaluating Long-Term Effects
Maxwell H. Levy, MD
Differentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
NeuroFrontiersDifferentiating gMG for Diagnostic Precision: The Role of Fatigable Weakness
Maxwell H. Levy, MD
Navigating Myasthenia Gravis in Adolescents and Young Adults
NeuroFrontiersNavigating Myasthenia Gravis in Adolescents and Young Adults
Jonathan Strober, MD
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
NeuroFrontiersRozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Gil I. Wolfe MD, FAAN
Henry Kaminski, MD
- advertisement
FcRn Inhibitors: A Potential New Targeted Therapy Option
NeuroFrontiersFcRn Inhibitors: A Potential New Targeted Therapy Option
Nicholas J. Silvestri, MD
NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
NeuroFrontiersNKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's RoundtableDiagnosing Myasthenia Gravis: The Impact of Social Media
Ashley Baker, MSN, PMHNP
Vishnu Pandurangadu, MD/MBA, FACEP
Pritikanta Paul, MD
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiersZilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Uncovering a Potential Biomarker for Myasthenia Gravis
NeuroFrontiersUncovering a Potential Biomarker for Myasthenia Gravis
- advertisement
